PCRS Webinar - Reducing the Steroid Burden: Medication Review for Patients With Asthma on Biologic Therapy
This webinar aims to provide healthcare professionals with essential insights and practical strategies for optimising medication regimens for patients with asthma on biologic therapy, with a specific focus on reducing the steroid burden. Biologic therapies have revolutionised the management of asthma, but their combination with steroids can pose challenges and risks to patients. We will be joined by guest speaker Professor Dinesh Saralaya and attendees will gain valuable knowledge on effective medication review techniques to enhance patient outcomes, minimise steroid-related side effects, and improve overall treatment efficacy.
Key Objectives:
- Understand the importance of medication review in patients on biologic therapy, especially those who are concurrently taking steroids.
- Recognise the risks and challenges associated with prolonged steroid use in asthma.
- Explore the role of biologic therapies in reducing the need for steroids and their potential to improve long-term outcomes.
- Identify patient-specific factors influencing the decision to reduce the steroid burden while on biologic therapy.
- Learn practical strategies and evidence-based approaches for tapering and discontinuing steroids safely.
- Discuss the potential benefits and limitations of steroid-sparing regimens involving biologic therapies.
- Address patient concerns and build effective communication strategies to promote adherence to treatment plans.
- Review case studies highlighting successful steroid reduction in patients with asthma on biologic therapy.
- Explore the latest research and emerging therapies that may further support steroid reduction.
Our webinars are for healthcare professionals only.
Thank you to our webinar sponsors, GSK.
This webinar has been instigated and organised by PCRS. The funding from the sponsor (GSK) has allowed us to provide this valuable educational meeting free of charge to all delegates. The sponsor has had no input into the agenda or the selection of speakers.
